Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Gall Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00238212
What this trial is testing

S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the Gallbladder+7 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT07641036
What this trial is testing

Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+2 more
Beijing Biotech 30
Early research (Phase 1)Study completedNCT00544193
What this trial is testing

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)UnknownNCT01317069
What this trial is testing

A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer

Who this might be right for
Gallbladder CancerBile Duct Cancer
Simcere Pharmaceutical Co., Ltd 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793253
What this trial is testing

Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer

Who this might be right for
Biliary Tract CancersIntrahepatic Cholangiocarcinoma (Icc)Extrahepatic Cholangiocarcinoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Not applicableLooking for participantsNCT07007832
What this trial is testing

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Who this might be right for
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Testing effectiveness (Phase 2)Study completedNCT04072445
What this trial is testing

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more
Mayo Clinic 28
Large-scale testing (Phase 3)Study completedNCT00513539
What this trial is testing

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 92
Testing effectiveness (Phase 2)Study completedNCT00059865
What this trial is testing

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 68
Large-scale testing (Phase 3)Study completedNCT00363584
What this trial is testing

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University Hospital Southampton NHS Foundation Trust 360
Testing effectiveness (Phase 2)Looking for participantsNCT05757336
What this trial is testing

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Who this might be right for
Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD 50
Not applicableStudy completedNCT02916199
What this trial is testing

Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method

Who this might be right for
Common Bile Duct StoneMalignant Hepatobiliary NeoplasmBiliary Stricture+2 more
Gangnam Severance Hospital 207
Not applicableWithdrawnNCT01875549
What this trial is testing

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Who this might be right for
Obstruction of Biliary TreeCholangiocarcinomaHepatocellular Carcinoma+2 more
Kwang Hyuck Lee
Not applicableStudy completedNCT04871321
What this trial is testing

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
CHA University 119
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Not applicableStudy completedNCT04456218
What this trial is testing

Clinical Evaluation of a Custom-made and Disposable Endoscope System for Biliary Tract

Who this might be right for
Biliary TractNeoplasmsStone - Biliary
National Cheng-Kung University Hospital 14
Testing effectiveness (Phase 2)Ended earlyNCT04203160
What this trial is testing

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 75
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Next Page